Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Cruz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Global Heart|April 24, 2017
Youth Engagement for NCD Prevention Policies: Rising NCD in India and Youth as Change EnablersIshu Kataria, Jennifer L Cruz
Therapeutic Advances in Drug Safety|August 5, 2015
Safety risks with investigational drugs: Pharmacy practices and perceptions in the veterans affairs health systemJennifer L Cruz, Jamie N Brown
Implementation Science Communications|December 6, 2025
Development of a practice-based skills measure for community-based organizations implementing evidence-based interventions to advance equityJennifer L Cruz, Scott R Rosas, Shoba Ramanadhan
Journal of Cardiovascular Pharmacology and Therapeutics|July 6, 2014
Use of erythropoiesis-stimulating agents in the treatment of anemia in patients with systolic heart failureDesirae E Lindquist, Jennifer L Cruz, Jamie N Brown
Journal of Clinical and Translational Science|March 13, 2026
Participatory systems modeling in implementation research: Exploring benefits, facilitators, and future needsNatalie Riva Smith, Jennifer L Cruz, Jessica Gannon, et al.
AJPM Focus|October 4, 2023
A Systematic Review Evaluating Disparities in State-Run Quitline Utilization and Effectiveness in the U.SDavid C Colston, Jennifer L Cruz, Bethany J Simard, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2018
The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label StudiesJohlee S Odinet, Chelsea E Day, Jennifer L Cruz, et al.
Therapeutic Advances in Chronic Disease|November 17, 2015
The effect of angiotensin II receptor blockers on hyperuricemiaMarissa L Wolff, Jennifer L Cruz, Adam J Vanderman, et al.
The Yale Journal of Biology and Medicine|March 31, 2017
Medication Safety in Clinical Trials: Role of the Pharmacist in Optimizing Practice, Collaboration, and Education to Reduce ErrorsJamie N Brown, Sara R Britnell, Andrew P Stivers, et al.
Therapeutic Advances in Neurological Disorders|April 30, 2015
The emerging role of tacrolimus in myasthenia gravisJennifer L Cruz, Marissa L Wolff, Adam J Vanderman, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Global Heart|April 24, 2017
Youth Engagement for NCD Prevention Policies: Rising NCD in India and Youth as Change EnablersIshu Kataria, Jennifer L Cruz
Therapeutic Advances in Drug Safety|August 5, 2015
Safety risks with investigational drugs: Pharmacy practices and perceptions in the veterans affairs health systemJennifer L Cruz, Jamie N Brown
Implementation Science Communications|December 6, 2025
Development of a practice-based skills measure for community-based organizations implementing evidence-based interventions to advance equityJennifer L Cruz, Scott R Rosas, Shoba Ramanadhan
Journal of Cardiovascular Pharmacology and Therapeutics|July 6, 2014
Use of erythropoiesis-stimulating agents in the treatment of anemia in patients with systolic heart failureDesirae E Lindquist, Jennifer L Cruz, Jamie N Brown
Journal of Clinical and Translational Science|March 13, 2026
Participatory systems modeling in implementation research: Exploring benefits, facilitators, and future needsNatalie Riva Smith, Jennifer L Cruz, Jessica Gannon, et al.
AJPM Focus|October 4, 2023
A Systematic Review Evaluating Disparities in State-Run Quitline Utilization and Effectiveness in the U.SDavid C Colston, Jennifer L Cruz, Bethany J Simard, et al.
Journal of Managed Care & Specialty Pharmacy|September 25, 2018
The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label StudiesJohlee S Odinet, Chelsea E Day, Jennifer L Cruz, et al.
Therapeutic Advances in Chronic Disease|November 17, 2015
The effect of angiotensin II receptor blockers on hyperuricemiaMarissa L Wolff, Jennifer L Cruz, Adam J Vanderman, et al.
The Yale Journal of Biology and Medicine|March 31, 2017
Medication Safety in Clinical Trials: Role of the Pharmacist in Optimizing Practice, Collaboration, and Education to Reduce ErrorsJamie N Brown, Sara R Britnell, Andrew P Stivers, et al.
Therapeutic Advances in Neurological Disorders|April 30, 2015
The emerging role of tacrolimus in myasthenia gravisJennifer L Cruz, Marissa L Wolff, Adam J Vanderman, et al.
Pageof 3